Drug Type Small molecule drug |
Synonyms Azelnidipine (JP17/INN), CS-905, RS 9054 + [5] |
Target |
Mechanism L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (31 Jan 2003), |
Regulation- |
Molecular FormulaC33H34N4O6 |
InChIKeyZKFQEACEUNWPMT-UHFFFAOYSA-N |
CAS Registry123524-52-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01145 | Azelnidipine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | JP | 31 Jan 2003 |
Not Applicable | 36 | dmmzgzrzay(xficlnlkhy) = fceqvdkmhu qjphaicyon (jwrilcwmuh ) | - | 01 Feb 2020 | |||
dmmzgzrzay(xficlnlkhy) = kzrbpjybxm qjphaicyon (jwrilcwmuh ) | |||||||
Not Applicable | - | - | (Aβ oligomers) | hkfuxxkjpp(dqdzijvahz) = shvtiozdzb thtiwonvvb (knjsjpspnb ) | - | 18 Oct 2015 | |
hkfuxxkjpp(dqdzijvahz) = sopiwvjdgn thtiwonvvb (knjsjpspnb ) |